Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
National survey finds HBV rate is four times higher than that of the overall U.S. population.
A new study appears to resolve controversy over hep C treatment’s association with mortality risk.
What do you know about hepatitis E?
An outbreak has prompted a mass vaccination effort.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
CDC’s Division of Viral Hepatitis is leading a national campaign called Know More Hepatitis.
This is one of several lawsuits filed by advocates on behalf of inmates with the liver virus in U.S. prisons.
Four things you should know to be #HepAware.
“Humberto truly understood the plight of people on the margins of society, of people who have the least access to health care.”
Clinical trials often exclude key patient populations, including children and people living with HIV or hepatitis B or C.
We will never end the HIV and hepatitis epidemics by preventing people with preexisting conditions from accessing care.
Aflatoxin, a food-borne chemical, is probably one of the leading causes of cancer in the developing world.
A brief overview of the differences between hepatitis A, B and C.
All the major world organizations, shareholders, some countries, and the state of New York are committed to the elimination of hepatitis C.
The case claims prison officials are knowingly denying HCV-positive inmates medical care, which may violate the U.S. Constitution.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.